Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference

    NEXT STORY
    AzurRx BioPharma Presents Positive Secondary Endpoint Data in its Phase II MS1819-SD Chronic Pancreatitis Study at the 2019 Digestive Disease Week Conference
    PREV STORY
    OSE Immunotherapeutics Receives Notice of Allowance for New U.S. Patent Protecting Anti-IL-7 Receptor Antagonist OSE-127
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Algernon Pharmaceuticals Appoints Leading Respirologist Dr. Martin Kolb to Its Medical and Scientific Advisory Board

    author_avatar
    NASDAQ Market News

    BriaCell Doses First Patient in Phase I/IIa Study Evaluating Bria-IMT™ in Combination with INCMGA00012 and Epacadostat in Patients with Advanced Breast Cancer

    author_avatar
    NASDAQ Market News

    PCI Biotech awarded NOK 13.8 million from The Research Council of Norway to further development of PCI for use in vaccination

    Oslo, Norway, January 27, 2017 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics ...

    author_avatar
    NASDAQ Market News